Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse

The risk of central nervous system (CNS) dissemination in mantle cell lymphoma (MCL) is low and occurs late in the course of the disease. However, prognosis in such cases remains extremely poor despite high-dose antimetabolite chemotherapy. Among novel drugs used to treat relapsing MCL patients, ibr...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Blood
मुख्य लेखकों: Bernard, Sophie, Goldwirt, Lauriane, Amorim, Sandy, Brice, Pauline, Brière, Josette, de Kerviler, Eric, Mourah, Samia, Sauvageon, Hélène, Thieblemont, Catherine
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2015
विषय:
Lymphoid Neoplasia
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591793/
https://ncbi.nlm.nih.gov/pubmed/26239089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-05-647834
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन